Joint Atomic Model
Takeda Expands De Novo Protein Research with Second AI-Driven Collaboration with Nabla Bio
Takeda; Nabla Bio; de novo protein design; AI drug discovery; Joint Atomic Model (JAM); multi-year collaboration; protein therapeutics; antibody design; biopharmaceutical innovation